Steve Beuchaw analyst

Currently out of the existing stock ratings of Steve Beuchaw, 20 are a SELL (22.99%), 36 are a HOLD (41.38%), 31 are a BUY (35.63%).

Steve Beuchaw

Work Performance Price Targets & Ratings Chart

Analyst Steve Beuchaw, currently employed carries an average stock price target met ratio of 76.22% that have a potential upside of 18.26% achieved within 270 days. Previously, Steve Beuchaw worked at WOLFE.

Steve Beuchaw’s has documented 174 price targets and ratings displayed on 18 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on QGEN, Qiagen NV at 16-Feb-2024.

Wall Street Analyst Steve Beuchaw

Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/9/2018. The price target of $320 was fulfilled within 1 day with a profit of $20.97 (6.15%) receiving and performance score of 61.5.

Average potential price target upside

ALGN Align Technology BRKR Bruker ILMN Illumina ISRG Intuitive Surgical MDT Medtronic PLC QGEN Qiagen NV SDC SmileDirectClub XRAY Dentsply Sirona A Agilent Technologies TMO Thermo Fisher Scientific DHR Danaher HSIC Henry Schein MYGN Myriad Genetics OCDX Ortho Clinical Diagnostics Holdings plc PDCO Patterson Companies MTD Mettler-Toledo International PKI PerkinElmer VAR Varian Medical Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$275

$48.08 (21.19%)

$285

28 days ago
(24-Oct-2024)

27/38 (71.05%)

$58.58 (27.07%)

149

Buy

$250

$23.08 (10.17%)

$270

28 days ago
(24-Oct-2024)

5/11 (45.45%)

$33.58 (15.52%)

273

Buy

$275

$48.08 (21.19%)

$285

28 days ago
(24-Oct-2024)

14/33 (42.42%)

$58.58 (27.07%)

93

Buy

$276

$49.08 (21.63%)

$325

28 days ago
(24-Oct-2024)

21/29 (72.41%)

$59.58 (27.53%)

97

Hold

$320

$93.08 (41.02%)

$260

7 months 6 days ago
(15-Apr-2024)

8/14 (57.14%)

$15.26 (5.01%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Steve Beuchaw?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?